Eucrisa: A Topical Solution for Mild to Moderate Eczema

Eucrisa Name Institution Date Eczema, also identified as atopic dermatitis, is a significant health problem recognized globally and is a concern to many physicians due to its prevalence. Its evidence in the US population has led to the discovery of Eucrisa (Crisaborole). Eucrisa eczema ointment is a new drug in the market. According to (Pfizer Inc 2016), the US Food and Drug Administration approved Eucrisa bringing relief to patients suffering from Eczema. Eucrisa is a pharmacological agent that is used to treat mild to moderate Eczema